Murray Jensen Joins United Cannabis Corp Medical Board


Jensen will Oversee Company’s New Drug Application (NDA) Process for Prana

DENVER, CO / ACCESSWIRE / September 13, 2017 / United Cannabis Corporation (OTCQB: CNAB) (the “Company” or “United Cannabis”) today announced that Murray Jensen has joined the Company’s Medical Advisory Board and is tasked with overseeing the Company’s Investigational New Drug (IND) application process with the Food and Drug Administration (FDA).

Mr. Jensen brings extensive expertise in drug development, with over 25 years’ experience in research for pharmaceutical, medical device and natural health products in a wide variety of therapeutic areas. He has held numerous senior clinical research positions at pharmaceutical and biotechnology companies, and for the past 15 years has served as Managing Director of ethica CRO Inc. where he is responsible for Business Operations and Clinical and Scientific Affairs.

Commenting on the appointment, Mr. Jensen stated, “United Cannabis has developed a noteworthy portfolio of phyto-therapeutic products and I am

... read more at:


Leave a Reply

Your email address will not be published. Required fields are marked *